Dual Pharmacological Targeting of the MAP Kinase and PI3K/mTOR Pathway in Preclinical Models of Colorectal CancerTodd M. Pitts, Stephen Leong|PLoS ONE|2014Cited by 52
The Insulin-like Growth Factor I Receptor/Insulin Receptor Tyrosine Kinase Inhibitor PQIP Exhibits Enhanced Antitumor Effects in Combination with Chemotherapy Against Colorectal Cancer ModelsSara A. Flanigan, Stephen Leong|Clinical Cancer Research|2010Cited by 44